Drug interactions for the following drug(s)
Applies to: metoprolol succinate 50 MG 24 HR Extended Release Oral Tablet <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
Mirabegron may decrease the antihypertensive activities of Metoprolol.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: metoprolol succinate 50 MG 24 HR Extended Release Oral Tablet <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 866436, name = 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1300797, name = 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq], tty = SBD). Drug1 is resolved to metoprolol, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Metoprolol and Mirabegron.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.